Dyadic International, Inc.
- DYAI
- NASDAQ
- Biotechnology
- Enzyme Development
- Protein Production Platform (C1)
$0.38
Today −7.35%Quote Oct 19, 2026, 08:00 PM UTC
−8.22%over the last month
Max drawdown −18.3%From 1-month high −18.3%3 months −74.1%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Dyadic International
Dyadic International, Inc. operates as a U.S.-based biotechnology platform company, specializing in the development, production, and commercialization of enzymes and other proteins. Its core activities are underpinned by a patented and proprietary C1 platform, alongside other advanced technologies.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
5
Market value
$15.3M
Quote Oct 19
Analyst target
$3.00
+687.6% from here
Floor
$0.37
1.8% below price
Resistance
$0.43
12.1% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about DYAIPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free